240 related articles for article (PubMed ID: 8633037)
1. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5).
Fujimoto J; Shiota M; Iwahara T; Seki N; Satoh H; Mori S; Yamamoto T
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4181-6. PubMed ID: 8633037
[TBL] [Abstract][Full Text] [Related]
2. The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up-regulation in rat 1a fibroblasts.
Wellmann A; Doseeva V; Butscher W; Raffeld M; Fukushima P; Stetler-Stevenson M; Gardner K
FASEB J; 1997 Oct; 11(12):965-72. PubMed ID: 9337149
[TBL] [Abstract][Full Text] [Related]
3. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis.
Bischof D; Pulford K; Mason DY; Morris SW
Mol Cell Biol; 1997 Apr; 17(4):2312-25. PubMed ID: 9121481
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry.
Shiota M; Fujimoto J; Takenaga M; Satoh H; Ichinohasama R; Abe M; Nakano M; Yamamoto T; Mori S
Blood; 1994 Dec; 84(11):3648-52. PubMed ID: 7949120
[TBL] [Abstract][Full Text] [Related]
5. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site.
Ladanyi M; Cavalchire G
Genes Chromosomes Cancer; 1996 Mar; 15(3):173-7. PubMed ID: 8721682
[TBL] [Abstract][Full Text] [Related]
6. The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma.
Johnson PW; Leek J; Swinbank K; Angus B; Roberts P; Markham AF; Selby PJ; MacLennan KA
Ann Oncol; 1997; 8 Suppl 2():65-9. PubMed ID: 9209644
[TBL] [Abstract][Full Text] [Related]
7. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining.
Lamant L; Meggetto F; al Saati T; Brugières L; de Paillerets BB; Dastugue N; Bernheim A; Rubie H; Terrier-Lacombe MJ; Robert A; Rigal F; Schlaifer D; Shiuta M; Mori S; Delsol G
Blood; 1996 Jan; 87(1):284-91. PubMed ID: 8547653
[TBL] [Abstract][Full Text] [Related]
8. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
Beylot-Barry M; Lamant L; Vergier B; de Muret A; Fraitag S; Delord B; Dubus P; Vaillant L; Delaunay M; MacGrogan G; Beylot C; de Mascarel A; Delsol G; Merlio JP
Am J Pathol; 1996 Aug; 149(2):483-92. PubMed ID: 8701987
[TBL] [Abstract][Full Text] [Related]
9. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
Dirks WG; Zaborski M; Jäger K; Challier C; Shiota M; Quentmeier H; Drexler HG
Leukemia; 1996 Jan; 10(1):142-9. PubMed ID: 8558920
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.
Shiota M; Nakamura S; Ichinohasama R; Abe M; Akagi T; Takeshita M; Mori N; Fujimoto J; Miyauchi J; Mikata A; Nanba K; Takami T; Yamabe H; Takano Y; Izumo T; Nagatani T; Mohri N; Nasu K; Satoh H; Katano H; Fujimoto J; Yamamoto T; Mori S
Blood; 1995 Sep; 86(5):1954-60. PubMed ID: 7655022
[TBL] [Abstract][Full Text] [Related]
11. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.
Morris SW; Kirstein MN; Valentine MB; Dittmer KG; Shapiro DN; Saltman DL; Look AT
Science; 1994 Mar; 263(5151):1281-4. PubMed ID: 8122112
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA).
Ouyang T; Bai RY; Bassermann F; von Klitzing C; Klumpen S; Miething C; Morris SW; Peschel C; Duyster J
J Biol Chem; 2003 Aug; 278(32):30028-36. PubMed ID: 12748172
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.
Shiota M; Mori S
Leukemia; 1997 Apr; 11 Suppl 3():538-40. PubMed ID: 9209450
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system.
Iwahara T; Fujimoto J; Wen D; Cupples R; Bucay N; Arakawa T; Mori S; Ratzkin B; Yamamoto T
Oncogene; 1997 Jan; 14(4):439-49. PubMed ID: 9053841
[TBL] [Abstract][Full Text] [Related]
15. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
Wood GS; Hardman DL; Boni R; Dummer R; Kim YH; Smoller BR; Takeshita M; Kikuchi M; Burg G
Blood; 1996 Sep; 88(5):1765-70. PubMed ID: 8781433
[TBL] [Abstract][Full Text] [Related]
16. MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
Xie J; Briggs JA; Morris SW; Olson MO; Kinney MC; Briggs RC
Exp Hematol; 1997 Oct; 25(11):1111-7. PubMed ID: 9328447
[TBL] [Abstract][Full Text] [Related]
17. The t(2;5) in human lymphomas.
Kadin ME; Morris SW
Leuk Lymphoma; 1998 Apr; 29(3-4):249-56. PubMed ID: 9684923
[TBL] [Abstract][Full Text] [Related]
18. Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells.
Nieborowska-Skorska M; Slupianek A; Xue L; Zhang Q; Raghunath PN; Hoser G; Wasik MA; Morris SW; Skorski T
Cancer Res; 2001 Sep; 61(17):6517-23. PubMed ID: 11522649
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation.
Mason DY; Pulford KA; Bischof D; Kuefer MU; Butler LH; Lamant L; Delsol G; Morris SW
Cancer Res; 1998 Mar; 58(5):1057-62. PubMed ID: 9500471
[TBL] [Abstract][Full Text] [Related]
20. A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma.
Trinei M; Lanfrancone L; Campo E; Pulford K; Mason DY; Pelicci PG; Falini B
Cancer Res; 2000 Feb; 60(4):793-8. PubMed ID: 10706082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
